Genesis Therapeutics

Genesis Therapeutics Rakes In $200M For AI-Powered Drug Discovery

Genesis Therapeutics recently joined the growing list of AI-powered drug discovery startups receiving venture funding this year. The company closed a $200 million Series B financing round, taking its total funding to date to more than $280 million.

By Katie Adams

Artificial Intelligence, BioPharma

AI drug discovery firm spins out of Stanford research

Another AI drug discovery firm has sprung up in Silicon Valley with seed investors, including Andreessen Horowitz, kicking in $4.1 million.

By Joel Berg

The Funding Model for Cancer Innovation is Broken — We Can Fix It

Closing cancer health equity gaps require medical breakthroughs made possible by new funding approaches.

By Eve McDavid - CEO of Mission-Driven Tech

Market Trends to Watch for Health Systems and Their Specialty Pharmacies

The future looks bright for the integrated specialty pharmacy model – for health systems, providers, and most importantly, for patients.

By Jake Gaffey, MBA, Chief Strategy Officer at Shields Health Solutions

Consumer / Employer

Health Executives on Digital Transformation in Healthcare

Hear executives from Quantum Health, Surescripts, EY, Clinical Architecture and Personify Health share their views on digital transformation in healthcare.

By MedCity News

Consumer / Employer

Health Executives on Digital Transformation in Healthcare

Hear executives from Quantum Health, Surescripts, EY, Clinical Architecture and Personify Health share their views on digital transformation in healthcare.

By MedCity News